Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-7.47	97.13	104.97
Graham Fair Price	-8.99	7.68	8.44
PEG	87.83	-1.28	-10.48
Price/Book	25.00	-13.37	-17.83
Price/Cash Flow	283.52	131.58	34.31
Prices/Earnings	6.41	30.97	29.10
Price/Sales	5.00	12.08	11.51
Price/FCF	283.52	131.58	34.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.00	0.71	0.70
Operating Margin	-20.95	0.11	0.14
ROA	-18.65	0.03	0.03
ROE	-0.15	-0.11	29.52
ROIC	0.05	0.03	-32.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	10.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.30	-0.39	29.64
EPS QOQ	-0.03	-0.24	-774.29
FCF QOQ	0.36	-0.79	118.91
Revenue QOQ	0.32	-0.23	-28.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	31.00	35.68	15.10
Inventory Turnover	255757000.00	0.00	inf
Debt/Capitalization	1.29	1.34	3.66
Quick Ratio	2.03	2.30	13.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-4.55	-4.93	-8.42
Cash	9.62	8.81	-8.39
Capex	-0.11	-0.08	21.92
Free Cash Flow	2.36	0.50	-78.80
Revenue	7.04	5.45	-22.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.21	2.49	12.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.86	16.53	19.19
Naive Interpretation	Member

06 - Financial Health · Bad

Rating